跳至主要内容
临床试验/ACTRN12605000172606
ACTRN12605000172606尚未招募不适用

lcerated hemangiomas treated with amorphous gel as compared with a hydrocolloid will show improved healing rates.

Royal Children's Hospital, Vic, Australia0 个研究点目标入组 50 人开始时间: 2005年8月18日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
Years 至 2 Years(—)
性别
All

入选标准

  • Infants with ulcerated hemangioma of infancy between the age of 0-2 years.

排除标准

  • Infants who have known hypersensitivity to amorphous gel or a hydrocolloid.Infants with other serious medical conditions requiring therapy.If the ulcerated hemangioma is at a site where dressing cannot be applied.Infants where surgical removal of the ulcer is regarded as the best treatment.

研究者

发起方
Royal Children's Hospital, Vic, Australia

相似试验